Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics, Annu Rev Anal Chem, vol.1, pp.45-69, 2008. ,
Metabolite profiling: from diagnostics to systems biology, Nat Rev Mol Cell Biol, vol.5, pp.763-769, 2004. ,
Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy, Chem Soc Rev, vol.40, pp.387-426, 2011. ,
The human serum metabolome, PLoS One, vol.6, p.16957, 2011. ,
Proposed minimum reporting standards for data analysis in metabolomics, Metabolomics, pp.231-241, 2007. ,
, The Human Metabolome Database
HMDB: the Human Metabolome Database, Nucleic Acids Res, vol.35, pp.521-526, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-01712873
Chemometrics in metabonomics, J Proteome Res, vol.6, pp.469-479, 2007. ,
Measuring the metabolome: current analytical technologies, Analyst, vol.130, pp.606-625, 2005. ,
Metabolic phenotyping in health and disease, Cell, vol.134, pp.714-717, 2008. ,
Oxygen: modulator of metabolic zonation and disease of the liver, Hepatology, vol.31, pp.255-260, 2000. ,
The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements, Pharmacogenomics, vol.6, pp.691-699, 2005. ,
Pharmacometabonomic identification of a significant hostmicrobiome metabolic interaction affecting human drug metabolism, Proc Natl Acad Sci, vol.106, pp.14728-14733, 2009. ,
Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans, Clin Pharmacol Ther, vol.88, pp.45-51, 2010. ,
1H NMR spectroscopy for the prediction of therapeutic outcome in patients with fulminant hepatic failure, NMR Biomed, vol.19, pp.521-526, 2006. ,
Detection of new amino acid markers of liver trauma by proton nuclear magnetic resonance spectroscopy, Liver Int, vol.26, pp.703-707, 2006. ,
Metabolomic Profiling of Autoimmune Hepatitis: The Diagnostic Utility of Nuclear Magnetic Resonance Spectroscopy, J Proteome Res, 2014. ,
The global burden of hepatitis C, Liver Int, vol.29, issue.1, pp.74-81, 2009. ,
Hepatitis C virus infection diagnosis using metabonomics, J Viral Hepat, vol.17, pp.854-858, 2010. ,
Metabolomic approach by 1H NMR spectroscopy of serum for the assessment of chronic liver failure in patients with cirrhosis, J Proteome Res, vol.10, pp.3239-3245, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00609858
Metabolite identification in human liver needle biopsies by high-resolution magic angle spinning 1H NMR spectroscopy, NMR Biomed, vol.19, pp.90-100, 2006. ,
Metabolic profile of chronic liver disease by NMR spectroscopy of human biopsies ,
, Int J Mol Med, vol.27, pp.111-117, 2011.
A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus, J Proteome Res, vol.6, pp.2413-2419, 2007. ,
Comparison of the metabolic profiling of hepatitis B virus-infected cirrhosis and alcoholic cirrhosis patients by using (1) H NMR-based metabonomics, Hepatol Res, vol.42, pp.677-685, 2012. ,
¹H NMR-based serum metabolic profiling in compensated and decompensated cirrhosis, World J Gastroenterol, vol.18, pp.285-290, 2012. ,
Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance, J Proteome Res, vol.9, pp.5180-5187, 2010. ,
Serum 1H-NMR metabolomic fingerprints of acute-on-chronic liver failure in intensive care unit patients with alcoholic cirrhosis, PLoS One, vol.9, p.89230, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02489938
Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis, Cancer Sci, vol.100, pp.782-785, 2009. ,
Identification of serum proton NMR metabolomic fingerprints associated with hepatocellular carcinoma in patients with alcoholic cirrhosis, Clin Cancer Res, vol.18, pp.6714-6722, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-02489955
Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study, J Proteome Res, vol.10, pp.1828-1836, 2011. ,
Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population, J Proteome Res, vol.9, pp.1096-1103, 2010. ,
Pathology of hepatocellular carcinoma and its precursors using proton magnetic resonance spectroscopy and a statistical classification strategy, Pathology, vol.34, pp.417-422, 2002. ,
A new NMR-based metabolomics approach for the diagnosis of biliary tract cancer, J Hepatol, vol.52, pp.228-233, 2010. ,
Early detection of graft failure using the blood metabolic profile of a liver recipient, Transplantation, vol.83, pp.517-521, 2007. ,
Proton nuclear magnetic resonance analysis of hepatic bile from donors and recipients in human liver transplantation, Transplantation, vol.72, pp.855-860, 2001. ,
Metabonomic analysis of hepatitis E patients shows deregulated metabolic cycles and abnormalities in amino acid metabolism, J Viral Hepat, vol.18, pp.591-602, 2011. ,
Schuppe-Koistinen I. A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran, Biomarkers, vol.14, pp.572-586, 2009. ,
Metabolic profiling of bile in cholangiocarcinoma using in vitro magnetic resonance spectroscopy, HPB (Oxford), vol.12, pp.396-402, 2010. ,
Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis, J Proteome Res, vol.6, pp.2605-2614, 2007. ,
Hepatic lipid profiling in chronic hepatitis C: an in vitro and in vivo proton magnetic resonance spectroscopy study, J Hepatol, vol.52, pp.16-24, 2010. ,
,